VEGFA and Keratoconjunctivitis sicca: Pioglitazone and 15d-PGJ2 may inhibit corneal neovascularization and scar formation in cornea alkali burn injury model and VEGF-induced cornea angiogenesis and exert a therapeutic effect in dry eye mice.